BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9409190)

  • 1. Eight-year experience of malignant lymphoma--survival and prognostic factors.
    Hahn JS; Lee S; Chong SY; Min YH; Ko YW
    Yonsei Med J; 1997 Oct; 38(5):270-84. PubMed ID: 9409190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Hodgkin's disease: a twenty-year follow-up of patients at a center in Korea.
    Cheong JW; Park SY; Roh JK; Suh CO; Hahn JS
    Yonsei Med J; 2006 Aug; 47(4):455-65. PubMed ID: 16941733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A; Berg R
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan.
    Chen WL; Tsai WC; Chao TY; Sheu LF; Chou JM; Kao WY; Chen YC; Ho CL
    Ann Hematol; 2010 Jun; 89(6):553-62. PubMed ID: 20012434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of some biochemical markers as prognostic factors in malignant lymphomas.
    Salem HA; Eissa LA; Rabbie AM; El-Helw LM; El-Gayar AM
    Pak J Pharm Sci; 2006 Jul; 19(3):219-30. PubMed ID: 16935830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors.
    Caballero MD; Rubio V; Rifon J; Heras I; García-Sanz R; Vázquez L; Vidriales B; del Cañizo MC; Corral M; Gonzalez M; León A; Jean-Paul E; Rocha E; Moraleda JM; San Miguel JF
    Bone Marrow Transplant; 1997 Sep; 20(6):451-8. PubMed ID: 9313877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleural effusion in patients with non-Hodgkin's lymphoma: a case-controlled study.
    Elis A; Blickstein D; Mulchanov I; Manor Y; Radnay J; Shapiro H; Lishner M
    Cancer; 1998 Oct; 83(8):1607-11. PubMed ID: 9781955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj Hospital.
    Sukpanichnant S; Sonakul D; Piankijagum A; Wanachiwanawin W; Veerakul G; Mahasandana C; Tanphaichitr VS; Suvatte V
    Cancer; 1998 Sep; 83(6):1197-204. PubMed ID: 9740086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
    Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
    Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of and response to combination chemotherapy and subsequent application of international prognostic index in non-Hodgkin's lymphoma--an experience from a medical center in Southern Taiwan.
    Hsieh CI; Su WC; Chien CH; Cuo YL; Chen TY; Kao RH; Tsao CJ
    Kaohsiung J Med Sci; 1996 Feb; 12(2):69-82. PubMed ID: 8709176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period.
    Ho FC; Todd D; Loke SL; Ng RP; Khoo RK
    Int J Cancer; 1984 Aug; 34(2):143-8. PubMed ID: 6381328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total registration of non-Hodgkin's lymphoma and Hodgkin's disease in Scotland: effect of deprivation and caseload on outcome.
    Ewing JC; White JM; Rattray A; Lessells A; Mackie MJ
    Hematology; 2003 Aug; 8(4):211-20. PubMed ID: 12911938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of the histological classification and staging for patients with a malignant non-Hodgkin lymphoma].
    Raemaekers JM; Snoeijen JJ; Bogman MJ; Rutten E; Strijk SP; Manni JJ
    Ned Tijdschr Geneeskd; 1993 Apr; 137(16):815-20. PubMed ID: 8487885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retrospective analysis of 304 cases of malignant lymphomas in pathology: study and practice of the WHO classification of lymphoid neoplasms].
    Yin HF; Li T; Li JX
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1556-60. PubMed ID: 14642107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic and immunophenotypic study of non-Hodgkin's lymphoma in Korea. Lymphoreticular Study Group of the Korean Society of Pathologists.
    Kim CW; Kim I; Ko YH; Cho H; Yang WI; Kwon GY; Lee DG; Moon HB; Suh CH; Juhng SW
    J Korean Med Sci; 1992 Sep; 7(3):193-8. PubMed ID: 1285918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
    Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
    Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elderly patients with non-Hodgkin's lymphoma: population-based results in The Netherlands.
    Maartense E; Hermans J; Kluin-Nelemans JC; Kluin PM; Van Deijk WA; Snijder S; Wijermans PW; Noordijk EM
    Ann Oncol; 1998 Nov; 9(11):1219-27. PubMed ID: 9862053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
    Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
    Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience.
    Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A
    Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.